0001367644-20-000061.txt : 20200513 0001367644-20-000061.hdr.sgml : 20200513 20200513194548 ACCESSION NUMBER: 0001367644-20-000061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200511 FILED AS OF DATE: 20200513 DATE AS OF CHANGE: 20200513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOULWAN GEORGE A CENTRAL INDEX KEY: 0001222197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 20874940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wf-form4_158941353141255.xml FORM 4 X0306 4 2020-05-11 0 0001367644 Emergent BioSolutions Inc. EBS 0001222197 JOULWAN GEORGE A 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2020-05-11 4 S 0 2000 85.1856 D 29950 D Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.1600 to $85.2200, inclusive. /s/ S. Scott Lieberman, Attorney-in-fact 2020-05-13